Endometrial immune Profiling and Precision Care Lead to Significantly Higher Live Birth Rates, MatriceLab Trial Shows

Contributed by: Business Wire

Logo

Tags

Medical Devices

Health

Hospitals

Clinical Trials

Research

Science

Endometrial

More Like This

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

Univfy® Publishes Study in Nature Communications, Validates Univfy Artificial Intelligence (AI)/Machine Learning (ML) Platform's Superior In Vitro Fertilization (IVF) Live Birth Predictions, Key to Improving IVF Access, Affordability and Clinical Outcomes

IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker Development for Immunotherapy Response

PR Newswire associated0

Ziwig Endotest®: Scientific Validation Published in NEJM Evidence

(Graphic: Business Wire)

Agendia Announces Publication Validating MammaPrint® Utility in Prediction of Extended Endocrine Therapy Benefit

PR Newswire associated0

FutureLife becomes first European fertility network to adopt an end-to-end AI fertility platform, in partnership with Alife Health

PR Newswire associated0

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine